Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

ICRF-159: current status and clinical prospects

R E Bellet, M Rozencweig, D D Von Hoff

    European Journal of Cancer
    |November 1, 1977
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Improvements in Survival and Clinical Benefit With Gemcitabine as First-Line Therapy for Patients With Advanced Pancreas Cancer: A Randomized Trial.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023
    Same author

    Positron emission tomography (PET) as a predictive measure in patients with metastatic pancreatic cancer and normal CA19-9 levels at baseline.

    Annals of oncology : official journal of the European Society for Medical Oncology·2016
    Same author

    Positron emission tomography response evaluation from a randomized phase III trial of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone for patients with metastatic adenocarcinoma of the pancreas.

    Annals of oncology : official journal of the European Society for Medical Oncology·2016
    Same author

    CA19-9 decrease at 8 weeks as a predictor of overall survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancer.

    Annals of oncology : official journal of the European Society for Medical Oncology·2016
    Same author

    Phase II trial of vatalanib in patients with advanced or metastatic pancreatic adenocarcinoma after first-line gemcitabine therapy (PCRT O4-001).

    Cancer chemotherapy and pharmacology·2014
    Same author

    Phase I pharmacokinetic and pharmacodynamic study of the pan-PI3K/mTORC vascular targeted pro-drug SF1126 in patients with advanced solid tumours and B-cell malignancies.

    European journal of cancer (Oxford, England : 1990)·2012
    Same journal

    Estrogens, estradiol receptors and peroxidase activity in human mammary carcinomas.

    European journal of cancer·1981
    Same journal

    Metastasis from the brain of transplanted N-ethyl-N-nitrosourea-induced central nervous system tumors in rats.

    European journal of cancer·1981
    Same journal

    Synergism between hyperthermia and cyclophosphamide in vivo: the effect of dose fractionation.

    European journal of cancer·1981
    Same journal

    Tumor inhibition by metallocenes: activity against leukemias and detection of the systemic effect.

    European journal of cancer·1981
    Same journal

    Effect of presurgical radiotherapy on the steroid receptor concentrations in primary breast carcinoma.

    European journal of cancer·1981
    Same journal

    A murine ovarian tumor with unique metastasizing capacity.

    European journal of cancer·1981
    See all related articles